← Evidence map

ArticleAdvances in therapy2023

Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection.

Cesar Lopez-Vinueza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37129772